Data from a comparative study found liraglutide and dulaglutide presented similar effectiveness as semaglutide in the ...

About 3 times as many of the children and teenagers taking dulaglutide had a glycated hemoglobin level of less than 7.0% at 26 weeks compared with those on placebo. Treatment with a once-weekly dose ...

Discover comprehensive details about Dulaglutide, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Results from a phase 3 study of patients with type 2 diabetes uncontrolled with metformin indicate that adding injections of the investigational glucagonlike peptide 1 (GLP-1)–receptor agonist ...

Please provide your email address to receive an email when new articles are posted on . Dulaglutide, semaglutide and tirzepatide had similar GI safety profiles. An increased risk for GI adverse events ...

Dulaglutide (Trulicity) effectively boosted blood glucose control in youth with type 2 diabetes, the AWARD-PEDS trial found. Over the 26-week trial, 51% of youth (ages 10 to <18 years) treated with ...

Credit: Getty Images. Dulaglutide is a glucagon-like peptide-1 receptor agonist. Once-weekly treatment with dulaglutide was found to improve glycemic control in adolescents with uncontrolled type 2 ...

- Trulicity, a weekly glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for adults with type 2 diabetes as an adjunct to diet and exercise INDIANAPOLIS, Sept. 18, 2014 /PRNewswire/ -- ...